No CrossRef data available.
Article contents
Foreword: Globe-Hopping Pharmaceuticals
Published online by Cambridge University Press: 06 January 2021
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Foreword
- Information
- Copyright
- Copyright © American Society of Law, Medicine and Ethics and Boston University 2006
References
1 Gilhooley, Margaret, Heal the Damage: Prescription Drug Consumer Advertisements and Relative Choice, 38 J. OF HEALTH LAW 1 (2005)Google Scholar; Nadal, Caroline L., The Societal Value of Prescription Drug Advertisements in the New Millenium: Targeted Consumers Become The Learned, 9 J.L. & POLY 451 (2001)Google Scholar; American Medical Association, Direct-to-Consumer Advertising of Prescription Drugs, 55 FOOD & DRUG L.J. 119 (2000)Google Scholar; Terzian, Tamar, Direct-to-Consumer Prescription Drug Advertising, 25 AM. J.L. & MED. 149 (91999)Google Scholar; Noah, Lars, Advertising Prescription Drugs to Consumers: Assessing the Regulatory and Liability Issues, 32 GA. L. REV. 141 (1997)Google Scholar.
2 World Health Organization, The Importance of Pharmacovigilance: Safety Monitoring of Medicinal Products (2002), available at http://whqlibdoc.who.int/hq/2002/a75646.pdf; Fontanarosa, Phil B. et. al., Postmarketing Surveillance—Lack of Vigilance, Lack of Trust, 292 JAMA 2647 (2004)CrossRefGoogle ScholarPubMed.
3 See generally, Symposium, The Dietary Supplement Health And Education Act: Regulation at a Crossroads, 31 AM. J.L. & MED. 147 (2005)Google Scholar.
4 European Medicines Agency, http://www.emea.eu.int/.
5 Australian New Zealand Therapeutic Products Authority, http://www.anztpa.org/index.htm.
6 The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, http://www.ich.org/cache/compo/276-254-1.html
7 World Trade Organization, World Trade Report: Exploring the Links Between Trade, Standards and the WTO, at xxiv (2005), available at http://www.wto.org/english/res_e/booksp_e/anrep_e/world_trade_report05_e.pdf. Textiles, iron and steel, for example, have smaller shares of global trade. Id.
8 Outterson, Kevin, Patent Buy-Outs for Global Disease Innovations for Low and Middle- Income Countries, 32 AM. J.L. & MED. 159 (2006)CrossRefGoogle ScholarPubMed.
9 Vernon, John A. et. al., The Economics of Pharmaceutical Price Regulation and Importation: Refocusing the Debate, 32 AM. J.L. & MED. 175 (2006)CrossRefGoogle ScholarPubMed.
10 Liang, Bryan A., Fade to Black: Importation and Counterfeit Drugs, 32 AM. J.L. & MED. 279 (2006)CrossRefGoogle ScholarPubMed.
11 Id. at 291-92.
12 Hollis, Aidan & Ibbott, Peter, How Parallel Trade Affects Drug Policies and Prices in Canada and the United States, 32 AM. J.L. & MED. 193 (2006)CrossRefGoogle ScholarPubMed.
13 Kleiman, Mary Ellen Fleck, State Regulation of Canadian Pharmacies: A Prescription to Violate the Supremacy Clause, 32 AM. J.L. & MED. 219 (2006)CrossRefGoogle ScholarPubMed.
14 Gilman, Daniel, Oy Canada! Trade's Non-Solution to “the Problem” of U.S. Drug Prices, 32 AM. J.L. & MED. 274 (2006).Google ScholarPubMed
15 Id. at 252.
16 Id. at 259.
17 Liang, supra note 10 at 281.
18 Id. at 294.
19 deKeiffer, Donald, Trojan Drugs: Counterfeit and Mislabeled Pharmaceuticals in the Legitimate Market, 32 AM. J.L. & MED. 325 (2006)CrossRefGoogle Scholar.
20 Gatter, Robert, Conflicts of Interest in International Human Drug Research and the Insufficiency of International Protections, 32 AM. J.L. & MED. 351 (2006)CrossRefGoogle ScholarPubMed.
21 Id. at 361.
22 Thomas, W. John, The Vioxx Story: Would it Have Ended Differently in the European Union? 32 AM. J.L. & MED. 381 (2006)Google ScholarPubMed.
You have
Access